|
Originally published In Press as doi:10.1074/jbc.M103257200 on May 30, 2001
J. Biol. Chem., Vol. 276, Issue 32, 30490-30498, August 10, 2001
Directing the Immune Response to Carbohydrate
Antigens*
Gina
Cunto-Amesty ,
Tarun K.
Dam§,
Ping
Luo ,
Behjatolah
Monzavi-Karbassi ,
C. Fred
Brewer§,
Thomas C.
Van
Cott¶, and
Thomas
Kieber-Emmons
From the Department of Pathology and Laboratory
Medicine, University of Pennsylvania,
Philadelphia, Pennsylvania 19104, the § Department of
Molecular Pharmacology and Microbiology and Immunology, Albert Einstein
College of Medicine, Bronx, New York 10461, and the ¶ Henry M. Jackson Foundation, Rockville, Maryland 20850
Peptide mimetics may substitute for
carbohydrate antigens in vaccine design applications. At present, the
structural and immunological aspects of antigenic mimicry, which
translate into immunologic mimicry, as well as the functional
correlates of each, are unknown. In contrast to screening peptide
display libraries, we demonstrate the feasibility of a
structure-assisted vaccine design approach to identify functional
mimeotopes. By using concanavalin A (ConA), as a recognition template,
peptide mimetics reactive with ConA were identified. Designed peptides
were observed to compete with synthetic carbohydrate probes for ConA
binding, as demonstrated by enzyme-linked immunosorbent assay and
isothermal titration calorimetry (ITC) analysis. ITC measurements
indicate that a multivalent form of one particular mimetic binds to
ConA with similar affinity as does trimannoside. Splenocytes from
mimeotope-immunized mice display a peptide-specific cellular response,
confirming a T-cell-dependent nature for the mimetic. As
ConA binds to the Envelope protein of the human immunodeficiency virus,
type 1 (HIV-1), we observed that mimeotope-induced serum also binds to
HIV-1-infected cells, as assessed by flow cytometry, and could
neutralize T-cell line adapted HIV-1 isolates in vitro,
albeit at low titers. These studies emphasize that mimicry is based
more upon functional rather than structural determinants that regulate
mimeotope-induced T-dependent antibody responses to
polysaccharide and emphasize that rational approaches can be employed
to develop further vaccine candidates.
*
This work was supported by National Institutes of Health
Grant AI44412.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology
and Laboratory Medicine, Rm. 205, John Morgan Bldg., 36th and Hamilton
Walk, Philadelphia, PA 19104-6082. Tel.: 215-898-2428; Fax:
215-898-2401.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. D. Pashov, J. Plaxco, S. V. Kaveri, B. Monzavi-Karbassi, D. Harn, and T. Kieber-Emmons
Multiple Antigenic Mimotopes of HIV Carbohydrate Antigens: Relating Structure and Antigenicity
J. Biol. Chem.,
October 6, 2006;
281(40):
29675 - 29683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. Clement, A. Fortune, A. Phalipon, V. Marcel-Peyre, C. Simenel, A. Imberty, M. Delepierre, and L. A. Mulard
Toward a Better Understanding of the Basis of the Molecular Mimicry of Polysaccharide Antigens by Peptides: THE EXAMPLE OF SHIGELLA FLEXNERI 5A
J. Biol. Chem.,
January 27, 2006;
281(4):
2317 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pashov, G. Canziani, B. Monzavi-Karbassi, S. V. Kaveri, S. MacLeod, R. Saha, M. Perry, T. C. VanCott, and T. Kieber-Emmons
Antigenic Properties of Peptide Mimotopes of HIV-1-associated Carbohydrate Antigens
J. Biol. Chem.,
August 12, 2005;
280(32):
28959 - 28965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Sanders, M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K. O. Lloyd, P. D. Kwong, and J. P. Moore
The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120
J. Virol.,
June 14, 2002;
76(14):
7293 - 7305.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|